Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18
N/A
50 Years
N/A
50 Years
N/A
Open (Enrolling by invite only)
Both
Infections, Human Cathelicidin Antimicrobial Peptide (hCAP-18)
Both
Infections, Human Cathelicidin Antimicrobial Peptide (hCAP-18)
Trial Information
Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18
Inclusion Criteria
Participants in VITAL (NCT 01169259) are eligible to participate in this ancillary study.
Please see NCT 01169259 for lists of inclusion and exclusion criteria.
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Outcome Measure:
upper respiratory infection
Outcome Time Frame:
one year
Safety Issue:
No
Authority:
United States: Food and Drug Administration
Study ID:
AI093723
NCT ID:
NCT01758081
Start Date:
July 2010
Completion Date:
June 2016
Related Keywords:
- Infections
- Human Cathelicidin Antimicrobial Peptide (hCAP-18)
- Communicable Diseases
- Infection
Name | Location |
|---|---|
| Brigham and Women's Hospital | Boston, Massachusetts 02115 |
